Department of Emergency Medicine, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07441, Korea.
Medicina (Kaunas). 2022 Mar 18;58(3):444. doi: 10.3390/medicina58030444.
Background and Objectives: This study assessed the prognostic value of underlying chronic kidney disease (CKD) and renal replacement therapy (RRT) on the clinical outcomes from out-of-hospital cardiac arrest (OHCA). Materials and Methods: This retrospective study was conducted utilizing the population-based OHCA data of South Korea between 2008 and 2018. Adult (>18 years) OHCA patients with a medical cause of cardiac arrest were included and classified into three categories based on the underlying CKD and RRT: (1) non-CKD group; (2) CKD without RRT group; and (3) CKD with RRT group. A total of 13,682 eligible patients were included (non-CKD, 9863; CKD without RRT, 1778; CKD with RRT, 2041). From the three comparison subgroups, data with propensity score matching were extracted. The influence of CKD and RRT on patient outcomes was assessed using propensity score matching and multivariate logistic regression analyses. The primary outcome was survival at hospital discharge and the secondary outcome was a good neurological outcome at hospital discharge. Results: The two CKD groups (CKD without RRT and CKD with RRT) showed no significant difference in survival at hospital discharge compared with the non-CKD group (CKD without RRT vs. non-CKD, p > 0.05; CKD with RRT vs. non-CKD, p > 0.05). The non-CKD group had a higher chance of having good neurological outcomes than the CKD groups (non-CKD vs. CKD without RRT, p < 0.05; non-CKD vs. CKD with RRT, p < 0.05) whereas there was no significant difference between the two CKD groups (CKD without RRT vs. CKD with RRT, p > 0.05). Conclusions: Compared with patients without CKD, the underlying cause of CKD—regardless of RRT—may be linked to poor neurological outcomes. Underlying CKD and RRT had no effect on the survival at hospital discharge.
本研究评估了基础慢性肾脏病(CKD)和肾脏替代治疗(RRT)对院外心脏骤停(OHCA)临床结局的预后价值。
本回顾性研究利用了韩国 2008 年至 2018 年的基于人群的 OHCA 数据。纳入患有医学原因导致心脏骤停的成年(>18 岁)OHCA 患者,并根据基础 CKD 和 RRT 将其分为以下三类:(1)非 CKD 组;(2)无 RRT 的 CKD 组;和(3)有 RRT 的 CKD 组。共纳入 13682 例符合条件的患者(非 CKD,9863 例;无 RRT 的 CKD,1778 例;有 RRT 的 CKD,2041 例)。从这三个比较亚组中提取了经过倾向评分匹配的数据。使用倾向评分匹配和多变量逻辑回归分析评估 CKD 和 RRT 对患者结局的影响。主要结局为出院时的生存率,次要结局为出院时的良好神经学结局。
与非 CKD 组相比,两个 CKD 组(无 RRT 的 CKD 和有 RRT 的 CKD)出院时的生存率无显著差异(无 RRT 的 CKD 与非 CKD 相比,p > 0.05;有 RRT 的 CKD 与非 CKD 相比,p > 0.05)。非 CKD 组有更好的机会获得良好的神经学结局,而非 CKD 组与 CKD 组(非 CKD 与无 RRT 的 CKD 相比,p < 0.05;非 CKD 与有 RRT 的 CKD 相比,p < 0.05)相比,两组 CKD 之间无显著差异(无 RRT 的 CKD 与有 RRT 的 CKD 相比,p > 0.05)。
与无 CKD 的患者相比,CKD 的基础病因(无论是否进行 RRT)可能与不良神经学结局有关。基础 CKD 和 RRT 对出院时的生存率无影响。